Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - POSNER BRIAN S
Last Updated 
25-Jul-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

POSNER BRIAN S: Declared Holdings
Company/RelationshipReportedShares  Ownership
Arch Capital Group Ltd.
Director
NasdaqGS:ACGL
(historical quotes, profile, SEC, other insiders)
9-May-1414,737  Direct
BG Medicine, Inc.
Director
NasdaqCM:BGMD
(historical quotes, profile, other insiders)
19-Nov-1220,000  Direct
Biogen Idec Inc.
Director
NasdaqGS:BIIB
(historical quotes, profile, other insiders)
24-Jul-145,700  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
24-Jul-14 300BIIB Disposition (Non Open Market) at $0 per share.
20-Jun-14 605BIIB Automatic Sale at $315 per share.
(Proceeds of $190,575)
13-Jun-14 700BIIB Automatic Sale at $310.50 per share.
(Proceeds of $217,350)
12-Jun-14 870BIIB Acquisition (Non Open Market) at $0 per share.
9-May-14 3,073ACGL Acquisition (Non Open Market)
31-Mar-14 3,000BIIB Automatic Sale at $296.11 - $300 per share.
(Proceeds of about $894,000)
19-Aug-13 2,500ACGL Purchase at $23.58 per share.
(Cost of $58,949)
2-Aug-13 5,000ACGL Purchase at $25.25 per share.
(Cost of $126,250)
12-Jun-13 1,305BIIB Acquisition (Non Open Market) at $0 per share.
11-Jun-13 2,020BIIB Automatic Sale at $219.62 per share.
(Proceeds of $443,632)
9-May-13 2,802ACGL Acquisition (Non Open Market)
18-Mar-13 4,500BIIB Automatic Sale at $174.81 per share.
(Proceeds of $786,645)
19-Nov-12 10,000BGMD Purchase at $1.17 per share.
(Cost of $11,700)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?